Cost-Effectiveness of Percutaneous Coronary Intervention With Drug Eluting Stents Versus Bypass Surgery for Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: Results From the FREEDOM TrialMAGNUSON, Elizabeth A; FARKOUH, Michael E; ABDALLAH, Mouin et al.Circulation (New York, N.Y.). 2013, Vol 127, Num 7, pp 820-831, issn 0009-7322, 12 p.Article

Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized TrialsFARKOUH, Michael E; BODEN, William E; SETHI, Sanjum S et al.Journal of the American College of Cardiology. 2013, Vol 61, Num 15, pp 1607-1615, issn 0735-1097, 9 p.Article

The Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial: Clinical and angiographic profile at study entryBANSILAL, Sameer; FARKOUH, Michael E; MURATOV, Victoria et al.The American heart journal. 2012, Vol 164, Num 4, pp 591-599, issn 0002-8703, 9 p.Article

Strategies for Multivessel Revascularization in Patients with DiabetesFARKOUH, Michael E; DOMANSKI, Michael; DESAI, Akshay S et al.The New England journal of medicine. 2012, Vol 367, Num 25, pp 2375-2384, issn 0028-4793, 10 p.Article